Aquestive Therapeutics
- Pharmaceutical Preparations
- Warren, New Jersey
Compensation history
Top executives at Aquestive Therapeutics received an average of $2M per person in annual compensation from 2018 to 2023.
Average pay of disclosed executives at Aquestive Therapeutics
By year
Executives
We found five executives who work or worked at Aquestive Therapeutics.
News
Aquestive Therapeutics CEO Daniel Barber's 2023 pay jumps 88% to $2.5M
April 26, 2024
Aquestive Therapeutics CEO Keith Kendall's 2021 pay jumps 59% to $2M
April 29, 2022
Aquestive Therapeutics CFO John Maxwell's 2020 pay jumps 24% to $1.3M
May 5, 2021
Aquestive Therapeutics CEO Keith Kendall's 2019 pay falls 67% to $2.6M
April 29, 2020
About Aquestive Therapeutics
- Industry classifications
- DivisionManufacturing
- Major groupChemicals And Allied Products
- Industry groupDrugs
- IndustryPharmaceutical Preparations
- Address30 Technology Drive, Warren, New Jersey 07059
- Phone908-941-1900
- Fiscal year endDecember 31
- Former names
- MonoSol Rx, Inc.Until March 26, 2008
Source: SEC filings on April 26, 2024, April 29, 2022, May 5, 2021, and April 29, 2020.